Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study

Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study

AimsThis three-year follow-up study aimed to elucidate whether sodium-glucose cotransporter-2 inhibitors (SGLT2is) have any protection against diabetic neuropathy and nephropathy in patients with type 2 diabetes via reducing variability in glycemia and extraglycemic factors or their averages.Methods...

Full description

Bibliographic Details
Main Authors:	Fukashi Ishibashi, Aiko Kosaka, Mitra Tavakoli
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-06-01
Series:	Frontiers in Endocrinology
Subjects:	SGLT2i diabetic microvascular complication protection against neuropathy and nephropathy glycemic variability extraglycemic factors modest glycemic control
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2022.864332/full

Similar Items

Impact of Normoglycemia in Reducing Microvascular Complications in Patients with Type 2 Diabetes: A Follow-Up Study
by: Fukashi Ishibashi, et al.
Published: (2018-03-01)

Role of sodium glucose cotransporter-2 inhibitors in type I diabetes mellitus
by: Ahmadieh H, et al.
Published: (2017-05-01)

Microalbuminuria as an index of diabetic nephropathy among chronic diabetic patients in Gumel, North Western Nigeria
by: H A Halliru, et al.
Published: (2016-01-01)

Sodium Glucose Cotransporter 2 (SGLT2) Inhibitors and CKD: Are You a #Flozinator?
by: Anoushka Krishnan, et al.
Published: (2023-04-01)

Thyroid function, glycemic control, and diabetic nephropathy in patients with type 2 diabetes over 24 months: prospective observational study
by: Hiroshi Iwakura, et al.
Published: (2023-07-01)

SGLT 2 inhibitors: Antidiabetic agents with promising effects beyond glucose control
by: Canan Ersoy
Published: (2020-01-01)

A Modest Minimalism?
by: Jaan Kangilaski
Published: (2008-12-01)

Greater Glycemic Burden Is Associated with Further Poorer Glycemic Control in Newly-Diagnosed Type 2 Diabetes Mellitus Patients
by: Wei-Lun Wen, et al.
Published: (2022-01-01)

Drug Safety Evaluation of Sodium-Glucose Cotransporter 2 Inhibitors in Diabetic Comorbid Patients by Review of Systemic Extraglycemic Effects
by: Omari MB, et al.
Published: (2024-03-01)

Is Modest Fashion Modest?
by: Elena Esposito
Published: (2020-05-01)

Understanding the Importance of Glycemic Index and Glycemic Load in the Management of Diabetes Mellitus
by: G. K. Pal
Published: (2011-04-01)

Public Communication of Technological Change: Modest and Less Modest Witnesses
by: Per Hetland
Published: (2016-12-01)

Diet and Glycemic Index in Children with Type 1 Diabetes
by: Alessia Quarta, et al.
Published: (2023-08-01)

Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study
by: C. R. L. Cardoso, et al.
Published: (2018-02-01)

Is There a Role for Diabetes-Specific Nutrition Formulas as Meal Replacements in Type 2 Diabetes?
by: Jarvis C. Noronha, et al.
Published: (2022-04-01)

Ferritin levels in children and adolescents with type 1 diabetes mellitus: relationship with microvascular complications and glycemic control
by: Kotb Abbass Metwalley, et al.
Published: (2020-08-01)

Portraits and Challenges of Indonesia’s Modest Fashion Industry on the Halal Industry Competition in the World
by: Viviyanti Yuniastuti, et al.
Published: (2023-02-01)

Glycemic Variability Impacted by SGLT2 Inhibitors and GLP 1 Agonists in Patients with Diabetes Mellitus: A Systematic Review and Meta-Analysis
by: Heeyoung Lee, et al.
Published: (2021-09-01)

Mechanisms of Diabetic Nephropathy Not Mediated by Hyperglycemia
by: Davide Viggiano
Published: (2023-10-01)

Assessing the temporal within-day glycemic variability during hospitalization in patients with type 2 diabetes patients using continuous glucose monitoring: a retrospective observational study
by: Ying Xing, et al.
Published: (2024-03-01)

The Efficacy of Canagliflozin on Type 2 Diabetic Nephropathy in Male Rats
by: Manal M.G. Mourad*, et al.
Published: (2023-07-01)

Magnitude and determinants of diabetic retinopathy among persons with diabetes registered at employee health department of a tertiary Eye Hospital of central Saudi Arabia
by: Rajiv Khandekar, et al.
Published: (2015-01-01)

Serum VEGF as a predictive marker of glycemic control and diabetic nephropathy in Chinese older adults with type 2 diabetes mellitus
by: Yanyan Jiang, et al.
Published: (2023-11-01)

Targeting predialysis glucose up to 180 mg/dl reduces glycemic variability in end stage diabetic nephropathy
by: Nikita Shah, et al.
Published: (2022-01-01)

Low-Glycemic-Index/Load Desserts Decrease Glycemic and Insulinemic Response in Patients with Type 2 Diabetes Mellitus
by: Vasiliki Argiana, et al.
Published: (2020-07-01)

Adenosine Deaminase Activity in Serum of Diabetics: A Reflection of Glycemic Profile?
by: Anirban Poddar, et al.
Published: (2023-06-01)

Uncontrolled type 1 diabetes among Egyptian adolescents; risk determinants and clinical outcomes
by: Safinaz Adel Elhabashy, et al.
Published: (2022-04-01)

Prevalence and predictors of diabetes distress and depression in people with type 1 diabetes
by: Abdullah AlOzairi, et al.
Published: (2024-03-01)

Penambahan inulin terhadap indeks glikemik dan beban glikemik cookies growol: pengembangan makanan selingan diabetes
by: Desty Ervira Puspaningtyas, et al.
Published: (2022-11-01)

Glycemic Index (GI) or Glycemic Load (GL) and Dietary Interventions for Optimizing Postprandial Hyperglycemia in Patients with T2 Diabetes: A Review
by: Dionysios Vlachos, et al.
Published: (2020-05-01)

Evaluation of Risk Factors for Diabetic Peripheral Neuropathy Among Saudi Type 2 Diabetic Patients with Longer Duration of Diabetes
by: Alshammari NA, et al.
Published: (2022-09-01)

Flash glucose monitoring in gestational diabetes mellitus: possibilities for assessing glycemic variability
by: F. O. Ushanova, et al.
Published: (2021-09-01)

Correlation between diabetic nephropathy and diabetic retinopathy as a long term complications of diabetes mellitus
by: Dervišević Muamer, et al.
Published: (2023-09-01)

Longitudinal effects of one‐leg standing time on neuropathy outcomes in association with glycemic control in non‐elderly patients with type 2 diabetes
by: Kazuhiro Sugimoto, et al.
Published: (2022-06-01)

IMPACT OF SUCCESSFUL TREATMENT OF HCV ON GLYCEMIC CONTROL IN TYPE 2 DIABETES PATIENTS
by: Muhammad Saeed Akhter, et al.
Published: (2019-09-01)

The Health Effects of Low Glycemic Index and Low Glycemic Load Interventions on Prediabetes and Type 2 Diabetes Mellitus: A Literature Review of RCTs
by: Maria Peres, et al.
Published: (2023-12-01)

SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes
by: Raffaele Marfella, et al.
Published: (2023-02-01)

Real-world evidence of generic dapagliflozin: Relevance and results from Indian multicenter retrospective study
by: Bipin K Sethi, et al.
Published: (2022-01-01)

The role of sodium-glucose cotransporter 2 inhibitors in the treatment of type 2 diabetes: from clinical research to real practice
by: I. V. Misnikova, et al.
Published: (2020-12-01)

Correlation of iron levels with glycemia and microvascular complications among type II diabetes mellitus patients in Najran university hospital
by: Nasser Alqahtani, et al.
Published: (2022-01-01)